Hagop M. Kantarjian, MD of MD Anderson Cancer Center goes over some possible next steps for Inotuzumab after it has received FDA approval for acute
Inotuzumab Next Steps After FDA Approval
Hagop M. Kantarjian, MD of MD Anderson Cancer Center goes over some possible next steps for Inotuzumab after it has received FDA approval for acute